Literature summary for 3.4.21.119 extracted from

Scorilas, A.; Borgono, C.A.; Harbeck, N.; Dorn, J.; Schmalfeldt, B.; Schmitt, M.; Diamandis, E.P.
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker (2004), J. Clin. Oncol., 22, 678-685.

Search for more literature for 3.4.21.119

Application

Application	Comment	Organism
medicine	patients with ovarian carcinoma, women with enzyme-positive tumors most often have early stage disease, no residual tumor after surgery and optimal debulking success. Patients with enzyme-positive tumors have a significantly longer progression-free survival and overall survival. Use of enzyme as biomarker for ovarian carcinoma	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	patients with ovarian carcinoma	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
ovary cancer cell	-	Homo sapiens	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)